As used in P.L. 2021, c. 18(C.26:2H-7.22 et al.):
"Angioplasty" or "percutaneous coronary intervention" means the mechanical reopening of an occluded vessel in the heart or corona using a balloon-tipped catheter.
"Applicant hospital" means a general hospital that has entered into a collaboration agreement with a cardiac surgery center licensed in New Jersey.
"Application" means all information required by the commissioner of an applicant hospital to determine compliance with P.L. 2021, c. 18(C.26:2H-7.22 et al.).
"C-PORT-E study" means the Atlantic Cardiovascular Patient Outcomes Research Team Elective Angioplasty Study clinical trial.
"Collaboration agreement" means an agreement between a licensed cardiac surgery center and a general hospital that includes:
"Commissioner" means the Commissioner of Health.
"Department" means the Department of Health.
"Elective angioplasty" means an angioplasty or percutaneous coronary intervention performed on a non-emergent basis.
"Full service adult diagnostic cardiac catheterization facility" means an acute care general hospital that provides invasive cardiac diagnostic services to adult patients without cardiac surgery backup, is equipped with laboratories, and performs at least 250 cardiac catheterizations each year.
"Primary angioplasty" means an angioplasty or percutaneous coronary intervention performed on an acute or emergent basis.
N.J.S. § 26:2H-7.22